Weeks 512: Dose Optimization As the dose increases toward the therapeutic target, weight loss accelerates, averaging 0.52 pounds per week
Together with the April 1 clarification, FDA is signaling that it was not joking when it expressed its intention to actively police GLP-1 compounded products that fall outside the FD&C Acts exemptions
The general recommendation is to alternate the injection sites for each weekly dose to minimize irritation, bruising, and pain
Tkachenko A, Havranek O
WHERE GLP-1S COME IN Originally developed to treat type 2 diabetes, GLP-1 injections like Ozempic, Wegovy, and Mounjaro have emerged as a beacon of hope for weight loss
This remains speculative, but it could explain why some users report UTIs specifically during the first few months of treatment, during the early weeks on semaglutide when the body is adjusting most dramatically